MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Clinical trial NCT03406962 · COMPLETED
Trial details
- NCT number
- NCT03406962
- Sponsor
- Magenta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-09
- Primary completion
- 2020-02-10
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.